The most effective and promising population health strategies to advance human papillomavirus vaccination.

Expert Rev Vaccines

b Department of Health Sciences Research, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery , Mayo Clinic, Rochester , MN , USA.

Published: October 2016

The US is failing to make substantive progress toward improving rates of human papillomavirus vaccine uptake. While the Healthy People 2020 goal for human papillomavirus (HPV) vaccination is 80%, the three-dose completion rate in the US in 2014 for 13- to 17-year-old females is less than 40%, and the rate for males is just above 20%. Experts point to a number of reasons for the poor HPV vaccination rates including parental concerns about safety, necessity, and timing. However, the evidence refuting these concerns is substantial. Efforts focusing on education and communication have not shown promise, but several population health strategies have reminder/recall systems; practice-focused strategies targeting staff, clinicians, and parents; assessment and feedback activities; and school-based HPV vaccination programs.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6684098PMC
http://dx.doi.org/10.1586/14760584.2016.1116947DOI Listing

Publication Analysis

Top Keywords

human papillomavirus
12
hpv vaccination
12
population health
8
health strategies
8
effective promising
4
promising population
4
strategies advance
4
advance human
4
vaccination
4
papillomavirus vaccination
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!